Zhihong LU
16
0
0
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 16 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
STimulation Electronically of Acupoints for Postoperative Delirium in elderlY Patients
Role: lead
Drawing Therapy for pReoperative Anxiety in Waiting (DRAW)
Role: lead
Optimized Strict Fluid Management Helps Improve Endpoints After Liver Dissection
Role: lead
Frequency of Electrical Acupoint Stimulation on Hypotension During Induction
Role: lead
Effect of Remimazolam on Postoperative Delirium
Role: lead
Acupoint Stimulation Improves Cognition Under Hypoxia
Role: lead
Electrical Acupoint Stimulation Reduces Intrathecal Anesthesia Induced Hypotension
Role: lead
Dose of Remimazolam in Children for Intubation
Role: lead
Dose of Remi in Children
Role: lead
Acupoint Stimulation and Cranial Endovascular Treatment
Role: lead
Acupoint Stimulation Alleviates Postoperative Nausea and Vomiting
Role: lead
Dexmedetomidine Improves Recovery After Cranial Aneurysm Surgery
Role: lead
Etomidate to Improve Outcome in Elderly Patients
Role: lead
Analgesia by Single or Dual Acupoints Stimulation After Radical Mastectomy
Role: lead
TEAS Enhanced Recovery After Laparoscopic Colon Surgery
Role: lead
Transcutaneous Electrical Acupoint Stimulation(TEAS) for Hepatic and Renal Dysfunction After Pneumoperitoneum
Role: lead
All 16 trials loaded